PROSTATE CARCINOMA METASTATIC IN THE BONE
Clinical trials for PROSTATE CARCINOMA METASTATIC IN THE BONE explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CARCINOMA METASTATIC IN THE BONE trials appear
Sign up with your email to follow new studies for PROSTATE CARCINOMA METASTATIC IN THE BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to zap spine tumors before they paralyze
Disease control OngoingThis study tests whether using heat (thermal ablation) followed by very precise radiation (stereotactic radiosurgery) can better control cancer that has spread to the spine and is pressing on the spinal cord. About 60 adults with various solid tumors (like lung, breast, or prosta…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:42 UTC
-
New Triple-Drug combo targets advanced prostate cancer before hormone treatment
Disease control OngoingThis phase 2 trial tests a combination of abiraterone, prednisone, and apalutamide in 60 men with hormone-naive prostate cancer that has spread. The goal is to see how long patients can stay on treatment and how well it controls the cancer. Participants must have high-risk featur…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Double-Drug attack shows promise for tough prostate cancer
Disease control OngoingThis study tests whether adding a chemotherapy drug (cabazitaxel) to a hormone therapy (abiraterone) works better than hormone therapy alone for men with advanced prostate cancer that has spread and stopped responding to initial treatment. About 223 men who have already received …
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New combo therapy aims to shrink advanced cancers
Disease control OngoingThis study tests the safety and effectiveness of combining the immunotherapy drug avelumab with other drugs and radiation in people with advanced cancers that have not responded to standard treatments. About 173 adults with various solid tumors, including prostate cancer, will re…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
New combo therapy aims to boost immune response in hard-to-treat prostate cancer
Disease control OngoingThis study looks at how well the hormone drug enzalutamide works alone or with a targeted radiation therapy (radium-223) in 30 men with advanced prostate cancer that has spread to bones and no longer responds to standard hormone treatment. The goal is to see changes in the cancer…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
Immunotherapy plus chemo shows promise against Tough-to-Treat cancers
Disease control OngoingThis early-phase trial studies whether adding the immunotherapy drug pembrolizumab to standard chemotherapy can help people with rare, aggressive small cell or neuroendocrine cancers of the bladder or prostate. About 15 participants with cancer that has spread will receive the co…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:05 UTC